Defunct Company
Total Trials
25
As Lead Sponsor
0
As Collaborator
Total Enrollment
57,317
NCT01231971
Alzheimer's Disease Neuroimaging Initiative 2
Phase: N/A
Role: Collaborator
Start: Feb 14, 2011
Completion: Nov 29, 2017
NCT01687153
A Study of Brain Aging in Vietnam War Veterans
Start: Oct 31, 2012
Completion: Sep 21, 2021
NCT01767909
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Phase: Phase 2/3
Start: Jan 8, 2014
Completion: Dec 11, 2018
NCT02008357
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Phase: Phase 3
Start: Feb 28, 2014
Completion: Jun 8, 2023
NCT02167256
A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Phase: Phase 2
Start: Dec 31, 2014
Completion: Feb 27, 2018
NCT02434393
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Start: Mar 4, 2015
Completion: May 31, 2027
NCT02418598
AADC Gene Therapy for Parkinson's Disease
Phase: Phase 1/2
Start: Apr 14, 2015
Completion: Mar 31, 2018
NCT02488720
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Start: Sep 8, 2015
Completion: Sep 29, 2023
NCT02850146
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
Phase: Phase 1
Start: Aug 31, 2016
NCT02854033
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Start: Oct 31, 2016
Completion: Dec 31, 2024
NCT02720445
Memory Improvement Through Nicotine Dosing (MIND) Study
Start: Jan 13, 2017
Completion: Sep 16, 2025
NCT03507257
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Start: Apr 30, 2018
Completion: May 31, 2026
NCT04004767
TRC-PAD Program: In-Clinic Trial-Ready Cohort
Start: Jun 4, 2019
Completion: Apr 1, 2024
NCT04165109
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Start: Jun 7, 2021
Completion: Dec 31, 2027
NCT05617014
Alzheimer's Disease Neuroimaging Initiative 4
Start: Jun 9, 2023
Completion: Jul 31, 2027
NCT06416072
Alzheimer's Plasma Extension
Start: Sep 21, 2023
Completion: Jun 30, 2028
NCT05644262
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
Start: Dec 18, 2023
Completion: Dec 31, 2025
NCT05573490
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
Start: Jan 11, 2024
NCT06033066
Financial Incentives and Recruitment to the APT Webstudy
Start: Mar 1, 2024
Completion: Apr 30, 2024
NCT07218120
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
Start: Jun 9, 2025
NCT06957418
Alzheimer's Tau Platform: Master Protocol
Start: Nov 1, 2025
Completion: Aug 31, 2028
NCT07167966
Alzheimer's Tau Platform: Regimen A - AADvac1
Start: Nov 30, 2025
NCT06911944
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Phase: Phase 4
Start: Dec 1, 2025
NCT07173803
The Progressive Supranuclear Palsy Clinical Trial Platform
Completion: Jul 31, 2029
NCT07217665
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1